Lv2
110 积分 2021-08-18 加入
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study
15天前
已完结
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
21天前
已完结
Generation and Characterization of Iduronidase-Cleavable ADCs
26天前
已完结
Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban
27天前
已关闭
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
1个月前
已完结
Delivery of Monomethyl Auristatin F to the Tumor Microenvironment with Noninternalizing Fibroblast Activation Protein-Cleavable Small Molecule–Drug Conjugates Elicits Potent In Vivo Anticancer Activity
1个月前
已完结
In vivo activation of FAP-cleavable small molecule-drug conjugates for the targeted delivery of camptothecins and tubulin poisons to the tumor microenvironment
1个月前
已完结
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
1个月前
已完结
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
2个月前
已完结
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
2个月前
已完结
皖公网安备34019202002308
